Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 7076 - 7100 of 7757 in total
Investigational
Matched Iupac: … carbamimidamidopentanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid
Experimental
T900607 has been used in trials studying the treatment of Liver Cancer and Gastric Cancer.
Investigational
Cilnidipine is a dihydropyridine calcium antagonist. It was jointly developed by Fuji Viscera Pharmaceutical Company, Japan and Ajinomoto, Japan and approved in 1995. Compared with other calcium antagonists, cilnidipine can act on the N-type calcium channel that existing sympathetic nerve end besides acting on L-type calcium channel that similar to...
Investigational
Niludipine is a calcium channel blocker.
Experimental
Investigational
Hydroxytriptolide has been investigated for the treatment of Rheumatoid Arthritis.
Investigational
Salvinorin A has been investigated for the basic science of Pharmaceutical Preparations.
Investigational
Experimental
Navitoclax has been used in trials studying the treatment and basic science of Solid Tumors, Non-Hodgkin's Lymphoma, EGFR Activating Mutation, Chronic Lymphoid Leukemia, and Hematological Malignancies, among others. Navitoclax is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins. It is a substance being studied in the treatment of...
Investigational
VNP40101M is a novel alkylating agent that has been used in trials studying the treatment of Leukemia, Lymphoma, Lung Cancer, Small Intestine Cancer, and Myelodysplastic Syndromes, among others.
Investigational
A metabolite from Penicillium brefeldianum that exhibits a wide range of antibiotic activity.
Experimental
Ethoxzolamide is a sulfonamide used as diuretic and in glaucoma. It inhibits carbonic anhydrase activity in proximal renal tubules to decrease reabsorption of water, sodium, potassium, bicarbonate. Its pharmacological activity thus confers the risk for hypokalemia.
Withdrawn
Displaying drugs 7076 - 7100 of 7757 in total